Cytokinetics, Incorporated · NASDAQ:CYTK

Malik Fady Ibraham sold 3,500 Cytokinetics, Incorporated shares (Form 4)

Traded Apr 21, 2026 · Filed Apr 21, 2026

On Apr 21, 2026, Malik Fady Ibraham (EVP Research & Development) sold 3,500 Cytokinetics, Incorporated shares at US$65.69 for US$230K under a trading plan, leaving 153,902 shares. Filed Apr 21, 2026 (Form 4).

Sold
3,500 shares
Price
US$65.69
Value
US$230K
Holding after
153,902 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP Research & Development

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 21, 2026Common StockOption exercise3,500US$7.80157,402Direct
Apr 21, 2026Common StockSale3,500US$65.69153,902Direct

Source

View original at SEC

Related